Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2014 2
2018 3
2019 5
2020 4
2021 9
2022 6
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean R. rolfe (138 results)?
Effect of Previous Disease-Modifying Therapy on Treatment Effectiveness for Patients Treated With Ocrelizumab.
Pfeuffer S, Rolfes L, Ingwersen J, Pul R, Kleinschnitz K, Korsen M, Räuber S, Ruck T, Schieferdecker S, Willison AG, Aktas O, Kleinschnitz C, Hartung HP, Kappos L, Meuth SG. Pfeuffer S, et al. Neurol Neuroimmunol Neuroinflamm. 2023 Apr 11;10(3):e200104. doi: 10.1212/NXI.0000000000200104. Print 2023 May. Neurol Neuroimmunol Neuroinflamm. 2023. PMID: 37041077 Free PMC article.
Kinetic and thermodynamic studies of purine repressor binding to corepressor and operator DNA.
Xu H, Moraitis M, Reedstrom RJ, Matthews KS. Xu H, et al. J Biol Chem. 1998 Apr 10;273(15):8958-64. doi: 10.1074/jbc.273.15.8958. J Biol Chem. 1998. PMID: 9535880 Free article.
., Lu, F., and Zalkin, H. (1994) J. Biol. Chem. 269, 24066-24072; Rolfes, R. J., and Zalkin, H. (1990) J. Bacteriol. 172, 5637-5642), and conversely guanine binding affinity was increased by the presence of operator. ...
., Lu, F., and Zalkin, H. (1994) J. Biol. Chem. 269, 24066-24072; Rolfes, R. J., and Zalkin, H. (1990) J. Bacteriol. 172, 5637 …
NK Cell Patterns in Idiopathic Inflammatory Myopathies with Pulmonary Affection.
Pawlitzki M, Nelke C, Rolfes L, Hasseli R, Tomaras S, Feist E, Schänzer A, Räuber S, Regner L, Preuße C, Allenbach Y, Benveniste O, Wiendl H, Stenzel W, Meuth SG, Ruck T. Pawlitzki M, et al. Cells. 2021 Sep 27;10(10):2551. doi: 10.3390/cells10102551. Cells. 2021. PMID: 34685530 Free PMC article.
Pumpless Extracorporeal Hemadsorption Technique (pEHAT): A Proof-of-Concept Animal Study.
Fiedler MO, Muellenbach RM, Rolfes C, Lotz C, Nickel F, Müller-Stich BP, Supady A, Lepper PM, Weigand MA, Meybohm P, Kalenka A, Reyher C. Fiedler MO, et al. J Clin Med. 2022 Nov 18;11(22):6815. doi: 10.3390/jcm11226815. J Clin Med. 2022. PMID: 36431292 Free PMC article.
Linear regression resulted in CytoSorb() blood flow [mL/min] = 4.226 MAP [mmHg] - 3.496 (R-square 0.8133) and Oxiris() blood flow [mL/min] = 3.267 MAP [mmHg] + 57.63 (R-square 0.8708), respectively. ...
Linear regression resulted in CytoSorb() blood flow [mL/min] = 4.226 MAP [mmHg] - 3.496 (R-square 0.8133) and Oxiris() blood flow [mL …
Symptoms, Viral Loads, and Rebound Among COVID-19 Outpatients Treated With Nirmatrelvir/Ritonavir Compared With Propensity Score-Matched Untreated Individuals.
Smith-Jeffcoat SE, Biddle JE, Talbot HK, Morrissey KG, Stockwell MS, Maldonado Y, McLean HQ, Ellingson KD, Bowman NM, Asturias E, Mellis AM, Johnson S, Kirking HL, Rolfes MAR, Olivo V, Merrill L, Battan-Wraith S, Sano E, McLaren SH, Vargas CY, Goodman S, Sarnquist CC, Govindaranjan P, Petrie JG, Belongia EA, Ledezma K, Pryor K, Lutrick K, Bullock A, Yang A, Haehnel Q, Rao S, Zhu Y, Schmitz J, Hart K, Grijalva CG, Salvatore PP. Smith-Jeffcoat SE, et al. Clin Infect Dis. 2024 May 15;78(5):1175-1184. doi: 10.1093/cid/ciad696. Clin Infect Dis. 2024. PMID: 37963102 Free PMC article.
We compared symptom and viral dynamics in individuals with COVID-19 who completed N/R treatment and similar untreated individuals. METHODS: We identified symptomatic participants who tested severe acute respiratory syndrome coronavirus 2-positive and were N/R eligib …
We compared symptom and viral dynamics in individuals with COVID-19 who completed N/R treatment and similar untreated individuals. ME …
Skin Reactions in Patients With Multiple Sclerosis Receiving Cladribine Treatment.
Rolfes L, Pfeuffer S, Hackert J, Pawlitzki M, Ruck T, Sondermann W, Korsen M, Wiendl H, Meuth SG, Kleinschnitz C, Pul R. Rolfes L, et al. Neurol Neuroimmunol Neuroinflamm. 2021 Apr 9;8(3):e990. doi: 10.1212/NXI.0000000000000990. Print 2021 May. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 33837059 Free PMC article.
ECMO for COVID-19 patients in Europe and Israel.
Lorusso R, Combes A, Lo Coco V, De Piero ME, Belohlavek J; EuroECMO COVID-19 WorkingGroup; Euro-ELSO Steering Committee. Lorusso R, et al. Intensive Care Med. 2021 Mar;47(3):344-348. doi: 10.1007/s00134-020-06272-3. Epub 2021 Jan 9. Intensive Care Med. 2021. PMID: 33420797 Free PMC article. No abstract available.
Evaluation of Age-Dependent Immune Signatures in Patients With Multiple Sclerosis.
Eschborn M, Pawlitzki M, Wirth T, Nelke C, Pfeuffer S, Schulte-Mecklenbeck A, Lohmann L, Rolfes L, Pape K, Eveslage M, Bittner S, Gross CC, Ruck T, Wiendl H, Meuth SG, Klotz L. Eschborn M, et al. Neurol Neuroimmunol Neuroinflamm. 2021 Oct 19;8(6):e1094. doi: 10.1212/NXI.0000000000001094. Print 2021 Nov. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34667129 Free PMC article.
32 results